Pulmonx Corporation Long Term Debt 2019-2024 | LUNG
Pulmonx Corporation long term debt from 2019 to 2024. Long term debt can be defined as the sum of all long term debt fields.
| Pulmonx Corporation Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $35 |
| 2022 | $17 |
| 2021 | $17 |
| 2020 | $17 |
| 2019 | $15 |
| 2018 | $34 |
| Pulmonx Corporation Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2024-09-30 | $37 |
| 2024-06-30 | $37 |
| 2024-03-31 | $32 |
| 2023-12-31 | $35 |
| 2023-09-30 | $37 |
| 2023-06-30 | $37 |
| 2023-03-31 | $37 |
| 2022-12-31 | $17 |
| 2022-09-30 | $12 |
| 2022-06-30 | $14 |
| 2022-03-31 | $17 |
| 2021-12-31 | $17 |
| 2021-09-30 | $14 |
| 2021-06-30 | $15 |
| 2021-03-31 | $16 |
| 2020-12-31 | $17 |
| 2020-09-30 | $47 |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2018-12-31 | $34 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||